Phase 2Enrolling by invitationAge-related condition
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
- Sponsor
- Adam Boxer (Academic or other)
- Enrollment
- 147 planned
- Conditions
- PSP - Progressive Supranuclear Palsy
- Interventions
- LM11A-31; Matching Placebo
- Ages
- adults, older adults
- Registry
- NCT07264283
Full record on ClinicalTrials.gov
From the registry
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.
Primary outcomes
- Disease progression
History
Primary completion expected
Last registry update
Started
Registered